AG0035WO

557795-19-4 | SU-11248

Chemical structure of SU-11248, CAS 557795-19-4
AG0035WO
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 557795-19-4
Catalog Number AG0035WO
Chemical Name SU-11248
IUPAC Name N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
InChI InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-
InChI Key WINHZLLDWRZWRT-ATVHPVEESA-N
MDL Number MFCD09260778
Molecular Formula C22H27FN4O2
Molecular Weight 398.4738
NSC Number 750690
SMILES C(C)N(CCNC(=O)C1=C(NC(=C1C)C=C1/C(NC2=CC=C(C=C12)F)=O)C)CC
UNII V99T50803M
Synonyms
5-(5-fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, SU 011248, SU 11248, SU-011248, SU-11248, SU011248, SU11248, sunitinib, sunitinib malate, Sutent, Sunitinib, 557795-19-4, Sutent, Sunitinib malate, SU11248, sunitinibum, Sunitinib Base, SU-11248, Su-011248, SU 11248, UNII-V99T50803M, 342641-94-5, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, CHEMBL535, N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide, CHEBI:38940, NSC750690, V99T50803M, (Z)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide, 341031-54-7, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, MFCD09260778, 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE, N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide, Sunitinib (INN), 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, Sunitinib (free base), Sunitinib [INN:BAN], C22H27FN4O2, HSDB 7932, (Z)-Sunitinib, 1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, 5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide, 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide, n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide, n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, Sutent (free base), yrrole-3-carboxamide, KS-5022, AC1NS62J, SCHEMBL8081, BDBM4814, GTPL5713, QCR-67, Sutent, Sunitinib, SU11248, CHEBI:91430, EX-A553, WINHZLLDWRZWRT-ATVHPVEESA-N, BCPP000057, K00588a, 5-(5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid (2-diethylaminoethyl)amide, AOB87111, ZINC3964325, CF-876, HY-10255A, s7781, AKOS015908193, AKOS025312424, AN-9681, API0024677, CS-1670, DB01268, NSC-750690, NCGC00164631-02, NCGC00164631-04, AJ-47545, EN002687, N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, Q572, SC-47294, AB0017673, AX8033294, LS-187023, LS-187648, ST2413814, AM20090630, FT-0083556, 95S194, D08552, J90060, W-2596, AB01273976-01, AB01273976-02, AB01273976_04, SR-00000000005, I01-1229, SR-00000000005-2, ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide, Z2568722545, N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-, 1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-p, 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid(2-diethylamino-ethyl)-amide, N-[2-(Diethylamino)ethyl]-5-(2-oxo-5-fluoroindoline-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, N-[5-(Trifluoromethyl)-2-pyridinyl]-trans-4-[[(1,1-dimethylethyl)sulfonyl]amino]cyclohexane-1-carboxamide, Sunitanib, Sunitinib [INN], PDGF TK antagonist, Sutent (TN), Sunitinib, Free base, Sunitinib malate [USAN], D0R0MW, UNII-LVX8N1UT73, cc-689, SU011248 L-malate salt, Sunitinib (Pan-TK inhibitor), PHA-290940AD, C22-H27-F-N4-O2, SU-11248J, SU011248, ACN-036767, CID5329102, CS-O-11750, SU 011248, NCGC00164631-01, SU-12662, SU010398, SU-010398, 2035B, C22-H27-F-N4-O2.C4-H6-O5, C473478, D000077210, 341031-54-7 (malate); 557795-19-4 (free base)., 5-(5-fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, B49,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited